Handari, S.D.; Rohman, M.S.; Sargowo, D.; Aulanni’am; Qosimah, D.; Lestari, B.; Nugraha, R.A.
Targeting Inflammation with Galectin-3 and PIIINP Modulation Among ST-Segment Elevation Acute Coronary Syndrome Patients Underwent Delayed Percutaneous Coronary Intervention. Biomedicines 2025, 13, 259.
https://doi.org/10.3390/biomedicines13020259
AMA Style
Handari SD, Rohman MS, Sargowo D, Aulanni’am, Qosimah D, Lestari B, Nugraha RA.
Targeting Inflammation with Galectin-3 and PIIINP Modulation Among ST-Segment Elevation Acute Coronary Syndrome Patients Underwent Delayed Percutaneous Coronary Intervention. Biomedicines. 2025; 13(2):259.
https://doi.org/10.3390/biomedicines13020259
Chicago/Turabian Style
Handari, Saskia Dyah, Mohammad Saifur Rohman, Djanggan Sargowo, Aulanni’am, Dahliatul Qosimah, Bayu Lestari, and Ricardo Adrian Nugraha.
2025. "Targeting Inflammation with Galectin-3 and PIIINP Modulation Among ST-Segment Elevation Acute Coronary Syndrome Patients Underwent Delayed Percutaneous Coronary Intervention" Biomedicines 13, no. 2: 259.
https://doi.org/10.3390/biomedicines13020259
APA Style
Handari, S. D., Rohman, M. S., Sargowo, D., Aulanni’am, Qosimah, D., Lestari, B., & Nugraha, R. A.
(2025). Targeting Inflammation with Galectin-3 and PIIINP Modulation Among ST-Segment Elevation Acute Coronary Syndrome Patients Underwent Delayed Percutaneous Coronary Intervention. Biomedicines, 13(2), 259.
https://doi.org/10.3390/biomedicines13020259
